Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Bristol-Myers Squibb
>
CV Division and Celgene Acquisition
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="anonymous, post: 6239901"]Explain how they would not still be underwater, "thanks to us"? You didn't explain shit all you did was say you talked to some dumbasses at Celgene. </p><p><br /></p><p>We didn't announce anything for how stock options would be managed. I would think IF they would transfer over in any regard (BMS has the option to just null and void the grants anyway) that they would transfer over with the same ratio as the current Celgene fair market stock price vs. the stock option strike price you currently have for Celgene stock. So if the options transfer, it would be the same concept from a ratio perspective: current BMY fair market stock price vs. a ratio of the stock option strike price you currently have. </p><p><br /></p><p>So for instance, to dumb it down for you, if Celgene stock is at 100, and you have a strike price of 120 for Celgene stock, aka under water, and BMY is at 50, the same ratio would be that you'd have a strike price of 60 for the BMY stock. Maybe you'll have 2 options for every one option that you had for Celgene, but you're still underwater. </p><p><br /></p><p>So explain to me how I am dumb, you fucking r*****.[/QUOTE]</p><p><br /></p>
[QUOTE="anonymous, post: 6239901"]Explain how they would not still be underwater, "thanks to us"? You didn't explain shit all you did was say you talked to some dumbasses at Celgene. We didn't announce anything for how stock options would be managed. I would think IF they would transfer over in any regard (BMS has the option to just null and void the grants anyway) that they would transfer over with the same ratio as the current Celgene fair market stock price vs. the stock option strike price you currently have for Celgene stock. So if the options transfer, it would be the same concept from a ratio perspective: current BMY fair market stock price vs. a ratio of the stock option strike price you currently have. So for instance, to dumb it down for you, if Celgene stock is at 100, and you have a strike price of 120 for Celgene stock, aka under water, and BMY is at 50, the same ratio would be that you'd have a strike price of 60 for the BMY stock. Maybe you'll have 2 options for every one option that you had for Celgene, but you're still underwater. So explain to me how I am dumb, you fucking r*****.[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Bristol-Myers Squibb
>
CV Division and Celgene Acquisition
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Bristol-Myers Squibb
>
CV Division and Celgene Acquisition
>